Bring the Next Generation Supplements to the Market

ENBIOSIS partners with leading pharmaceutical, food, and supplier companies to expand the global reach of AI-designed, microbiome-driven products.

BECOME A PARTNER

Why Partner
with ENBIOSIS?

Why Partner with ENBIOSIS?

ENBIOSIS offers more than a single product, it provides a scalable technology platform built on strong scientific and clinical foundations.

Our approach combines clinically supported research, a clear roadmap across disease and wellness areas, and flexible product formats such as powder and bar, all designed for efficient scaling through ongoing R&D.

Our first market-ready product, ENBIOSIS Nutra for Dry Eye, serves as the foundation for a broader and expanding pipeline.

Partnership Oppurtunities

Collaboration models designed to support market expansion, portfolio growth, and long-term value creation.

Distribution Partnerships

We collaborate with regional and global partners to commercialize ENBIOSIS Nutra products in new markets.

Commercial Partnership

We work with strategic partners to co-market, license, and expand ENBIOSIS Nutra products through joint commercial initiatives, private-label opportunities, and shared go-to-market strategies.

Who We Work With?

Pharmaceutical & biotechnology companies

Partner with ENBIOSIS to expand your portfolio with science-backed, microbiome-driven health solutions.

Food & functional nutrition companies

Integrate AI-designed microbiome science into functional products of next-generation supplements.

Ingredient & supplier companies

Apply AI & microbiome intelligence to elevate innovation and unlock new application opportunities.

A Platform Built for Scale

ENBIOSIS products are developed with global scalability in mind, from formulation and manufacturing to regulatory and commercialization pathways.

Our pipeline continues to expand across multiple microbiome-linked indications, creating ongoing opportunities for partners to grow alongside the platform.

Become a Partner

Get in touch with us if you are interested in distributing, collaborating, or exploring strategic opportunities with ENBIOSIS.

Let’s build the future of microbiome-driven health, together.

Scientific Results. Business Impact.

Get instant access to our peer-reviewed studies, published in world-class journals.

🟥 The American Journal of Gastroenterology – 85% IBS symptom improvement
🟨 Gut Microbes – Microbiome diversity & symptom relief
🟩 Journal of Clinical Medicine – AI diet outperforms laxatives
🟦 Food Bioscience – Probiotic safety alerts

*We’ll send the download link to your inbox. No spam – just science.

BECOME A PARTNER

BECOME A PARTNER

Why Partner
with ENBIOSIS?

Why Partner with ENBIOSIS?

Partnership Oppurtunities

Distribution Partnerships

Commercial Partnership

A Platform Built for Scale

Become a Partner

Our Story

Digital Twin AI

Clinical Studies

Publications

Product Catalogue

Product Formats

Longevity

Category Availability

Licensing Model

Become a Partner

Global Regions

Contact Us